Atlas Trials

Clinical and Microbial Efficacy of Besifloxacin Ophthalmic Suspension, 0.6% in the Treatment of Bacterial Conjunctivitis

Clinical trial NCT01740388 · TERMINATED

Trial details

NCT number
NCT01740388
Sponsor
Bausch & Lomb Incorporated
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Bacterial Conjunctivitis
Start date
2013-02-01
Primary completion
2013-07-01
Enrollment
136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.